Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS reforms

- PMLiVE

Charity demands action on cancer drug prices in UK

Breakthrough Breast Cancer wants commitment from all political parties

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

The future of pharmacy in the UK

Community pharmacy dispensing is being challenged on three fronts

- PMLiVE

NICE backs GSK’s Tafinlar for skin cancer

Joins Yervoy and Zelboraf as a recommended melanoma treatment

- PMLiVE

Pressure put on Roche to cut Kadcyla’s UK price

30,000 people sign petition to help make the breast cancer drug available on the NHS

National Institute for Health and Care Excellence NICE logo

NICE working to tackle antimicrobial resistance

Two guidelines in development to improve NHS use of antibiotic drugs

National Institute for Health and Care Excellence NICE logo

NICE publishes its first medicines optimisation guidance

Draft guidelines encourage patient-centred care and improved NHS communications

- PMLiVE

NHS England invests £120m to tackle mental health

Standards to put mental illness on equal footing with physical health issues

ABPI London offices

Half of England’s adults say NHS spends too little on drugs

Medicines account for 10p of every £1 spent by NHS, says ABPI

National Institute for Health and Care Excellence NICE logo

NICE denies two drugs in new MS guidance

Sativex and Fampyra too costly for NHS in England

- PMLiVE

Cancer Drugs Fund could take on a price assessment role

NHS England consults on a series of significant changes to Fund

- PMLiVE

NICE recommends Lundbeck’s alcohol dependency drug

NHS patients to have access to Selincro to help control drinking

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links